PPAR
Showing all 8 results
-
Adipogenesis
BADGE | PPAR gamma antagonist
BADGE (1675-54-3) is a PPARγ antagonist with μM affinity in 3T3-L1 and 3T3-F442A preadipocyte cells. Selective over PPARδ and PPARα. Antagonizes th...$30.00 – $100.00 Select options -
Adipogenesis
Ciglitazone | PPARgamma agonist
Ciglitazone (74772-77-3) is a PPARγ agonist (EC50=3 μM). Stimulates adipogenesis in human mesenchymal stem cells. Ciglitazone inhibits HUVEC differ...$80.00 – $320.00 Select options -
New Products
Elafibranor | PPARalpha/delta agonist
Elafibranor (923978-27-2) is a dual PPARα/δ agonist (EC50 PPARα = 10-20 nM; PPARδ = 100-150 nM).1 It was able to decrease plasma triglycerides leve...$65.00 – $235.00 Select options -
Cardiovascular
GW-501516 | PPAR delta agonist
GW-501516 (317318-70-0) is a potent and selective PPARδ (NR1C2) agonist, EC50=1.2 nM and 1000-fold selective over other PPAR subtypes.1 Induces ap...$55.00 – $190.00 Select options -
Bioactive Lipids
Oleoylethanolamide | GPR119 agonist: stimulates lipolysis
Oleoylethanolamide (111-58-0) is an endogenous anandamide-like lipid acting as a PPARα agonist but does not bind to cannabinoid receptors.1 Biosynt...$50.00 – $200.00 Select options -
Approved Drugs
Pioglitazone HCl | PPAR gamma agonist
Pioglitazone (112529-15-4) is a clinically useful antidiabetic drug.1 It is a selective agonist of the human peroxisome proliferator-activated rece...$30.00 – $100.00 Select options -
Diabetes
Rosiglitazone maleate | PPAR gamma agonist
Rosiglitazone (155141-29-0) is a prototypical TZD antidiabetic agent. Potent and selective PPARγ agonist (Kd=43 nM).1,2 Clinically useful antihype...$55.00 – $150.00 Select options -
Adipogenesis
Troglitazone | PPARgamma agonist
Troglitazone (97322-87-7) is a PPARγ agonist. Stimulates recruitment of transcriptional coactivators to PPARγ at 1 μM. Stimulates adipogenesis in h...$86.00 – $344.00 Select options
